Development of T cell receptor‐engineered T cells targeting the sarcoma‐associated antigen papillomavirus binding factor

TCR engineered T cells for solid tumor immunotherapy

(2022) Yikai Zhang et al.   Experimental Hematology & Oncology

Development of CAR-T cells specifically targeting cancer stem cell antigen DNAJB8 against solid tumours

(2022) Yuto Watanabe et al.   BRITISH JOURNAL OF CANCER

TCR gene-engineered cell therapy for solid tumors

(2021) Elaine Tan et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Dysregulation of Zinc Finger Protein 395 Contributes to the Pathogenesis of Chondrosarcoma

(2021) Changbao Chen et al.   OncoTargets and Therapy

Peptide vaccinations elicited strong immune responses that were reboosted by anti-PD1 therapy in a patient with myxofibrosarcoma

(2019) Tomohide Tsukahara et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Development of a T-cell receptor multimer with high avidity for detecting a naturally presented tumor-associated antigen on osteosarcoma cells

(2018) Kazue Watanabe et al.   CANCER SCIENCE

NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma

(2015) Aaron P Rapoport et al.   NATURE MEDICINE

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

(2014) P. F. Robbins et al.   CLINICAL CANCER RESEARCH

The Hypoxia-Inducible Transcription Factor ZNF395 Is Controlled by IĸB Kinase-Signaling and Activates Genes Involved in the Innate Immune Response and Cancer

(2013) Darko Jordanovski et al.   PLoS One

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

(2011) Paul F. Robbins et al.   JOURNAL OF CLINICAL ONCOLOGY

Mixed T cell receptor dimers harbor potentially harmful neoreactivity

(2010) M. M. van Loenen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Scythe/BAT3 regulates apoptotic cell death induced by papillomavirus binding factor in human osteosarcoma

(2009) Tomohide Tsukahara et al.   CANCER SCIENCE

Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma

(2008) Tomohide Tsukahara et al.   CANCER SCIENCE